Nanotherapeutics in Cancer Treatment
- Authors: Niyati H. Patel1, Fahad Hassan Shah2
-
View Affiliations Hide AffiliationsAffiliations: 1 Middlesex County Academy of Allied Health and Biomedical Sciences, New Jersey, United States 2 Department of Biological Sciences, College of Natural Sciences, Kongju National University, Gongju, Korea
- Source: Nanotherapeutic Strategies and New Pharmaceuticals (Part 1) , pp 85-103
- Publication Date: November 2021
- Language: English
Nanotherapeutics in Cancer Treatment, Page 1 of 1
< Previous page | Next page > /docserver/preview/fulltext/9789815036695/chapter-5-1.gif
Nanotherapeutics is an advancing technology and promising industry of the 21st century; with further development, it may hold secrets for the medical community and society as a whole. The development of nanotherapeutics into medicine is one of the newest developments in medical science that the scientific community has taken. The conventional approach of delivering anticancer drugs towards the targeted site is remained controversial and has numerous problems such as non-specific effects to the surrounding organs other than cancer affected, anticancer drug resistance, and chronic adverse effects. Recently, biomedical scientists have turned their attention towards nanocarriers possessing incredible activity to deliver anticancer drugs towards canceraffected areas without being disrupted by endogenous barriers, rendering lesser toxicity and promoting anticancer response. In this chapter, the overview of nanotherapeutic agents is thoroughly assessed in the treatment of cancers.
-
From This Site
/content/books/9789815036695.chapter-5dcterms_subject,pub_keyword-contentType:Journal105
